Iovance Biotherapeutics, Inc. , a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells.
Iovance Biotherapeutics stock last closed at $1.88, up 1.62% from the previous day, and has decreased 76.96% in one year. It has underperformed other stocks in the Biotechnology industry by 0.05 percentage points. Iovance Biotherapeutics stock is currently +14.7% from its 52-week low of $1.64, and -84.97% from its 52-week high of $12.51.
There are currently 333.93M IOVA shares outstanding. The market cap of IOVA is $627.80M. In the past 24 hours, 9.7M IOVA shares were traded.
How to Buy Iovance Biotherapeutics Stock
Not sure how to invest in Iovance Biotherapeutics stock? Here's how.
Figure out where to buy Iovance Biotherapeutics stock: You need to choose an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Iovance Biotherapeutics stock.
Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Deposit funds into your investment account: Select your method of payment and add your details.
Evaluate Iovance Biotherapeutics stock: The Iovance Biotherapeutics ticker symbol is IOVA. Is Iovance Biotherapeutics stock a good investment? Should you buy shares of IOVA? How do IOVA's underlying business fundamentals look? Do top analysts think Iovance Biotherapeutics is a good buy? Why has IOVA's stock price moved recently? (Hint: Our stock research tools can help you evaluate if IOVA is a good stock to buy).
Place your IOVA purchase: Decide if you will purchase IOVA shares at the current market price or use a limit order to purchase IOVA stock at a given price.
Get key alerts regarding your IOVA position: Create a watchlist to the latest updates on your position in Iovance Biotherapeutics shares.
Step 1: Figure out where to buy Iovance Biotherapeutics stock
You need a brokerage account in order to access the NASDAQ market and buy IOVA shares.
A brokerage account enables you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our research, eToro is the best brokerage. Here's why:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to global markets: From Tech to Utilities, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've chosen the right brokerage, the next step is to fill out some personal info so you are able to buy IOVA stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Iovance Biotherapeutics stock
After you have selected the best place to buy Iovance Biotherapeutics stock, it's crucial to evaluate their stock prior to buying, so you can understand the risk and upside.
Iovance Biotherapeutics Metrics
IOVA Price
$1.88
1w %
-6.93%
1y %
-76.96%
5y %
-93.45%
P/E
-1.53x
P/B
0.82x
P/S
2.85x
PEG
N/A
Revenue
$212.68M
Earnings
-$375.36M
Fore. Rev. Growth
53.44%
Fore. Earn. Growth
N/A
Market Cap
$627.80M
Next Earnings
N/A
Next Dividend
N/A
IOVA Overview
WallStreetZen was designed to help average investors do more accurate fundamental analysis in less time.
IOVA has cash burn of 347501000. It has sufficient cash and short-term investments to cover this for at least one year.
There are more short-term assets than long-term liabilities on the IOVA balance sheet.
IOVA has a low debt to equity ratio of 0.26.
There are more short-term assets than short-term liabilities on the IOVA balance sheet.
Failed Health Checks:
IOVA has $366.09M in cash and short term investments. This is not enough to cover its annual cash burn of $347.50M.
Total IOVA debt is higher than 5 years ago, relative to shareholder equity.
IOVA profit margin has gone up by 234.39 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy Iovance Biotherapeutics stock, according to analysts?
Out of 9 Equities analysts who research IOVA, the consensus analyst rating on IOVA is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent IOVA Analyst Ratings
Joseph Pantginis, a bottom 1% analyst from HC Wainwright & Co. maintains IOVA with a buy rating and lowers their IOVA price target from $32.00 to $20.00, on May 9, 2025.
Asthika Goonewardene, a bottom 4% analyst from Truist Securities maintains IOVA with a strong buy rating and lowers their IOVA price target from $25.00 to $15.00, on Mar 3, 2025.
Michael Ulz, a top 10% analyst from Baird maintains IOVA with a buy rating and lowers their IOVA price target from $24.00 to $20.00, on Feb 28, 2025.
Joseph Catanzaro, a bottom 3% analyst from Piper Sandler maintains IOVA with a hold rating and lowers their IOVA price target from $7.50 to $6.00, on Feb 28, 2025.
Last year, IOVA revenue was $212.68M. In the past 1 years, IOVA's revenue has increased by 11,070.12% per year. This was faster than the Biotechnology industry average of 42.72%.
No, Iovance Biotherapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about IOVA?
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your IOVA purchase
You have two main order types:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are mostly the best for newer investors.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at an exact dollar amount, use a limit order.
Hit the Open Trade button and your broker will place your order.
If you want additional assistance investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Iovance Biotherapeutics share?
As of Jun 24, 2025, it costs $1.88 to buy one share of Iovance Biotherapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.94, you can buy 0.5 shares of IOVA.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.